TranS1, a pioneer in minimally invasive approaches to lumbar spine surgery, has announced it has received CE mark approval to market its VEO lateral access fusion system for interbody fusions.
“We are very pleased to receive the CE Mark for the VEO lateral system. This approval represents a significant milestone for TranS1 and will contribute to our efforts to become a leader in minimally invasive spine surgery. We are excited to begin executing on our commercialisation strategy in Europe as we enter the third quarter,” said Ken Reali, president and CEO, TranS1.
The VEO minimally invasive lateral system features an innovative, two-stage retraction method that focuses on nerve visualisation and then controlled retraction. The VEO system is designed for direct visualisation of the psoas muscles and adjacent nerves prior to muscle dissection.
The VEO retractor is complemented by a full range of PEEK lateral interbody implants and a variety of ergonomic instruments. Radiopaque markers are strategically located within the implants to allow proper placement.
